Researchers Dr. Tony Lam & Song-Yang Zhang at the Toronto General Hospital Research Institute (TGHRI) have discovered that the drug metformin acts through the kidney to lower weight and treat obesity.
Metformin is the first-line medication for the treatment of obesity-associated type 2 diabetes and has been in use for close to 30 years to lower blood sugar levels. It has also been documented to cause weight loss; however, exactly how it mediates weight loss was uncertain until now.
#kidney #researchseries #metformin #weightloss #uhn #torontogeneral #medicalresearch
www.livingorgandonation.ca
www.uhntransplant.ca
livingorgandonation@uhn.ca
